JBC Origene Your Gene Company

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on December 17, 2004
This Article
Right arrow Full Text (Accepted Manuscript)
Right arrow All Versions of this Article:
279/51/53028    most recent
M411136200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fessenden, J. D.
Right arrow Articles by Allen, P. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fessenden, J. D.
Right arrow Articles by Allen, P. D.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Papers In Press, published online ahead of print October 6, 2004
J. Biol. Chem, 10.1074/jbc.M411136200
Submitted on September 28, 2004
Revised on October 6, 2004
Accepted on October 6, 2004

Mutational analysis of putative calcium binding motifs within the skeletal ryanodine receptor isoform, RyR1

James D. Fessenden, Wei Feng, Isaac N. Pessah, and P. D. Allen

Department of Anesthesia Research, Boston Biomedical Research Institute, Watertown, MA 02472

Corresponding Author: fessenden{at}bbri.org

The functional relevance of putative Ca2+-binding motifs previously identified with Ca2+ overlay binding analysis within the skeletal muscle ryanodine receptor isoform (RyR1) was examined using mutational analysis. EF hands between amino acid positions 4081-4092 (EF1) and 4116-4127 (EF2) were scrambled singly or in combination within the full-length rabbit RyR1 cDNA. These cDNAs were expressed in 1B5 RyR-deficient myotubes and channel function assessed using Ca2+ imaging techniques, [3H]ryanodine binding measurements and single channel experiments. In intact myotubes, these mutations did not affect functional responses to either depolarization or RyR agonists (caffeine, 4-chloro-m-cresol) compared to wtRyR1. However, in [3H]ryanodine binding measurements, both Ca2+ activation and inhibition of the EF1 mutant was significantly altered compared to wtRyR1. No high affinity [3H]ryanodine binding was observed in membranes expressing the EF2 mutation, although in single channel measurements, the EF2-disrupted channel could be activated by micromolar Ca2+ concentrations. In addition, micromolar levels of ryanodine placed these channels into the classical half-conductance state, thus indicating that occupancy of high affinity ryanodine binding sites is not required for ryanodine-induced subconductance states in RyR1. Disruption of three additional putative RyR1 calcium binding motifs located between amino acid positions 4254-4265 (EF3), 4407-4418 (EF4) or 4490-4502 (EF5) either singly or in combination (EF3-5) did not affect functional responses in 1B5 myotubes except that the EC50 for caffeine activation for the EF3 construct was significantly increased compared to wtRyR1. However, in [3H]ryanodine binding experiments, the Ca2+-dependent activation and inactivation of mutated RyRs containing EF3, EF4, or EF5 was unaffected compared to wtRyR1.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Biophys. JHome page
A. J. Tanskanen, J. L. Greenstein, A. Chen, S. X. Sun, and R. L. Winslow
Protein Geometry and Placement in the Cardiac Dyad Influence Macroscopic Properties of Calcium-Induced Calcium Release
Biophys. J., May 15, 2007; 92(10): 3379 - 3396.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. R. Jacobson, S. T. Moe, P. D. Allen, and J. D. Fessenden
Structural Determinants of 4-Chloro-m-cresol Required for Activation of Ryanodine Receptor Type 1
Mol. Pharmacol., July 1, 2006; 70(1): 259 - 266.
[Abstract] [Full Text] [PDF]


Home page
Biophys. JHome page
L. Xiong, J.-Z. Zhang, R. He, and S. L. Hamilton
A Ca2+-Binding Domain in RyR1 that Interacts with the Calmodulin Binding Site and Modulates Channel Activity
Biophys. J., January 1, 2006; 90(1): 173 - 182.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
K. M. Ranatunga, T. M. Moreno-King, B. Tanna, R. Wang, S. R. W. Chen, L. Ruest, W. Welch, and A. J. Williams
The Gln4863Ala Mutation within a Putative, Pore-Lining Trans-Membrane Helix of the Cardiac Ryanodine Receptor Channel Alters Both the Kinetics of Ryanoid Interaction and the Subsequent Fractional Conductance
Mol. Pharmacol., September 1, 2005; 68(3): 840 - 846.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.